文摘
Aiming at identifying biomarkers for bladder cancer, the urinary proteome was explored through atwo-dimensional gel-based proteomic approach (2D-DIGE) coupled with mass spectrometry anddatabase interrogation. The increased expression of proteins differentially expressed between patientswith bladder tumors and controls such as Reg-1 and keratin 10 was confirmed to be associated withbladder cancer progression on bladder cancer cell lines by immunoblotting, and bladder tumors byimmunohistochemistry. Moreover, the association of these proteins, especially Reg-1, with tumor stagingand clinical outcome was confirmed by immunohistochemistry using an independent series of bladdertumors contained in tissue microarrays (n = 292). Furthermore, Reg-1 was quantified using anindependent series of urinary specimens (n = 80) and provided diagnostic utility to discriminate patientswith bladder cancer and controls (area under the curve (AUC = 0.88)). Thus, the 2D-DIGE approachhas identified Reg-1 as a biomarker for bladder cancer diagnostics, staging, and outcome prognosis.